NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

Indian Hotels Maintains Strong Performance Amid Geopolitical Tensions

Indian Hotels (IHCL) has reported a stable Q4FY26 performance, with same-store enterprise revenue per available room (RevPAR) increasing by 10% year-over-year (YoY). This growth comes despite geopolitical tensions, with consolidated revenue and earnings before interest, taxes, depreciation, and amortization (EBITDA) both rising by 14% YoY.

IHCL's confidence in double-digit revenue growth for FY27 is reflected in its rebounding demand in April and May 2026. With a significant operational presence of approximately 33,100 keys as of April 2026, the company has a substantial pipeline of around 31,300 keys over the next 4-5 years. Based on this, ICICI Securities has factored in a 12% revenue compound annual growth rate (CAGR) and a 15% EBITDA CAGR over FY26-28E for its hotels, excluding the Taj Sats.

Outlook and Recommendations

Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

ICICI Securities retains a BUY recommendation for Indian Hotels, with a revised target price of INR 916, based on a 32x December 2027 estimated enterprise value to EBITDA multiple. This revised target price reflects a trimming of FY26-28E EBITDA by approximately 1-1.5% each, taking into account lower growth for the Taj Sats air catering business.

CompanyFY26-28E Revenue CAGRFY26-28E EBITDA CAGR
Indian Hotels (IHCL)12%15%
(excluding Taj Sats)(excluding Taj Sats)

Note: The revenue and EBITDA CAGRs are estimates for the period FY26-28E and are based on ICICI Securities' research report.

Investor Takeaway

Investors should consider buying Indian Hotels due to its stable Q4FY26 performance and potential for double-digit revenue growth for FY27.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.